641 related articles for article (PubMed ID: 31075818)
1. The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.
Milenkovic VM; Stanton EH; Nothdurfter C; Rupprecht R; Wetzel CH
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075818
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmune Advance in Depressive Disorder.
Zhao G; Liu X
Adv Exp Med Biol; 2019; 1180():85-98. PubMed ID: 31784958
[TBL] [Abstract][Full Text] [Related]
3. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.
Na KS; Jung HY; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():277-86. PubMed ID: 23123365
[TBL] [Abstract][Full Text] [Related]
4. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies.
Stuart MJ; Baune BT
Neurosci Biobehav Rev; 2014 May; 42():93-115. PubMed ID: 24513303
[TBL] [Abstract][Full Text] [Related]
5. Physical Exercise and Neuroinflammation in Major Depressive Disorder.
Ignácio ZM; da Silva RS; Plissari ME; Quevedo J; Réus GZ
Mol Neurobiol; 2019 Dec; 56(12):8323-8335. PubMed ID: 31228000
[TBL] [Abstract][Full Text] [Related]
6. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.
Stuart MJ; Singhal G; Baune BT
Front Cell Neurosci; 2015; 9():357. PubMed ID: 26441528
[TBL] [Abstract][Full Text] [Related]
8. An altered peripheral IL6 response in major depressive disorder.
Money KM; Olah Z; Korade Z; Garbett KA; Shelton RC; Mirnics K
Neurobiol Dis; 2016 May; 89():46-54. PubMed ID: 26804030
[TBL] [Abstract][Full Text] [Related]
9. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
10. Nitric Oxide and Major Depressive Disorder: Pathophysiology and Treatment Implications.
Kudlow P; Cha DS; Carvalho AF; McIntyre RS
Curr Mol Med; 2016; 16(2):206-15. PubMed ID: 26812915
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
[TBL] [Abstract][Full Text] [Related]
12. A detailed examination of cytokine abnormalities in Major Depressive Disorder.
Simon NM; McNamara K; Chow CW; Maser RS; Papakostas GI; Pollack MH; Nierenberg AA; Fava M; Wong KK
Eur Neuropsychopharmacol; 2008 Mar; 18(3):230-3. PubMed ID: 17681762
[TBL] [Abstract][Full Text] [Related]
13. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression.
Kim YK; Na KS; Myint AM; Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():277-84. PubMed ID: 26111720
[TBL] [Abstract][Full Text] [Related]
14. Chemokines and their receptors in the central nervous system.
Bajetto A; Bonavia R; Barbero S; Florio T; Schettini G
Front Neuroendocrinol; 2001 Jul; 22(3):147-84. PubMed ID: 11456467
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression.
Verduijn J; Milaneschi Y; Schoevers RA; van Hemert AM; Beekman AT; Penninx BW
Transl Psychiatry; 2015 Sep; 5(9):e649. PubMed ID: 26418277
[TBL] [Abstract][Full Text] [Related]
16. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.
Khairova RA; Machado-Vieira R; Du J; Manji HK
Int J Neuropsychopharmacol; 2009 May; 12(4):561-78. PubMed ID: 19224657
[TBL] [Abstract][Full Text] [Related]
17. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Köhler CA; Freitas TH; Stubbs B; Maes M; Solmi M; Veronese N; de Andrade NQ; Morris G; Fernandes BS; Brunoni AR; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
Mol Neurobiol; 2018 May; 55(5):4195-4206. PubMed ID: 28612257
[TBL] [Abstract][Full Text] [Related]
18. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease.
Xia MQ; Hyman BT
J Neurovirol; 1999 Feb; 5(1):32-41. PubMed ID: 10190688
[TBL] [Abstract][Full Text] [Related]
19. A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders.
Ślusarczyk J; Trojan E; Chwastek J; Głombik K; Basta-Kaim A
Curr Neuropharmacol; 2016; 14(7):705-20. PubMed ID: 26893168
[TBL] [Abstract][Full Text] [Related]
20. The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets.
Ascoli BM; Géa LP; Colombo R; Barbé-Tuana FM; Kapczinski F; Rosa AR
Aust N Z J Psychiatry; 2016 Jul; 50(7):618-30. PubMed ID: 27091850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
